KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $547.5 million.

  • Bio-Rad Laboratories' Change in Account Payables rose 390.97% to $547.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 3.4%. This contributed to the annual value of $2.1 billion for FY2025, which is 3.4% up from last year.
  • Latest data reveals that Bio-Rad Laboratories reported Change in Account Payables of $547.5 million as of Q4 2025, which was up 390.97% from $517.5 million recorded in Q3 2025.
  • Bio-Rad Laboratories' Change in Account Payables' 5-year high stood at $620.3 million during Q2 2023, with a 5-year trough of $446.4 million in Q3 2024.
  • Over the past 5 years, Bio-Rad Laboratories' median Change in Account Payables value was $538.8 million (recorded in 2021), while the average stood at $544.7 million.
  • In the last 5 years, Bio-Rad Laboratories' Change in Account Payables surged by 3005.24% in 2022 and then crashed by 1867.19% in 2024.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Change in Account Payables stood at $530.0 million in 2021, then grew by 14.62% to $607.5 million in 2022, then dropped by 14.68% to $518.3 million in 2023, then rose by 1.65% to $526.9 million in 2024, then grew by 3.91% to $547.5 million in 2025.
  • Its Change in Account Payables was $547.5 million in Q4 2025, compared to $517.5 million in Q3 2025 and $505.9 million in Q2 2025.